Strata Skin Sciences, Inc.
SSKN
$2.59
-$0.03-1.15%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 33.56M | 32.68M | 32.73M | 32.55M | 33.36M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 33.56M | 32.68M | 32.73M | 32.55M | 33.36M |
| Cost of Revenue | 14.48M | 14.55M | 14.96M | 15.39M | 14.90M |
| Gross Profit | 19.08M | 18.13M | 17.77M | 17.15M | 18.46M |
| SG&A Expenses | 23.59M | 23.25M | 21.85M | 22.53M | 23.46M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 38.96M | 38.86M | 37.88M | 39.17M | 39.68M |
| Operating Income | -5.39M | -6.19M | -5.15M | -6.62M | -6.32M |
| Income Before Tax | -10.26M | -9.48M | -8.41M | -11.46M | -10.92M |
| Income Tax Expenses | -170.00K | -92.00K | -92.00K | -92.00K | -92.00K |
| Earnings from Continuing Operations | -10.09 | -9.38 | -8.31 | -11.36 | -10.83 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.09M | -9.38M | -8.31M | -11.36M | -10.83M |
| EBIT | -5.39M | -6.19M | -5.15M | -6.62M | -6.32M |
| EBITDA | -426.00K | -1.17M | 80.00K | -1.22M | -767.00K |
| EPS Basic | -2.59 | -2.60 | -2.37 | -3.25 | -3.10 |
| Normalized Basic EPS | -1.22 | -1.39 | -1.25 | -1.48 | -1.38 |
| EPS Diluted | -2.59 | -2.60 | -2.37 | -3.25 | -3.10 |
| Normalized Diluted EPS | -1.22 | -1.39 | -1.25 | -1.48 | -1.38 |
| Average Basic Shares Outstanding | 15.22M | 14.55M | 14.01M | 13.99M | 13.97M |
| Average Diluted Shares Outstanding | 15.22M | 14.55M | 14.01M | 13.99M | 13.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |